Novo Nordisk’s Ozempic And Wegovy Under Scrutiny Amid Reports Of ‘Stomach Paralysis’

Popular weight loss and diabetes drugs, Ozempic and Wegovy, have reportedly caused stomach paralysis in some users.

What Happened: Life-altering side effects are causing some to question whether the benefits of the Novo Nordisk A/S (NYSE:NVO) produced medications outweigh the costs, according to CNN.

The drugs function by mimicking a hormone called GLP-1 that slows food passage through the stomach, helping users feel fuller longer. However, the stomach can slow down excessively, leading to severe gastroparesis, or stomach paralysis.

Two patients, Joanie Knight and Emily Wright, claim their debilitating conditions are the result of Novo Nordisk’s medications.

The U.S. Food and Drug …

Full story available on Benzinga.com

Read More

Tags

Share this post:

JOIN THE HYVE

Gain insights, receive dynamic opportunities directly to your inbox. Sign up now…